Outcomes and Therapeutic Management of Bladder Cancer
Bladder cancer is the second most common genitourinary malignancy, with 81,190 estimated new diagnoses in 2018, in the United States alone. Transurethral resection of the bladder and radical cystectomy with bilateral pelvic lymph node dissection constitute the standard treatment for non-muscle invas...
Sparad:
| Materialtyp: | Online |
|---|---|
| Språk: | engelska |
| Utgiven: |
MDPI - Multidisciplinary Digital Publishing Institute
2021
|
| Ämnen: | |
| Länkar: | ONIX_20210501_9783039369348_825 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|
| _version_ | 1869516070951321600 |
|---|---|
| collection | Directory of Open Access Books |
| description | Bladder cancer is the second most common genitourinary malignancy, with 81,190 estimated new diagnoses in 2018, in the United States alone. Transurethral resection of the bladder and radical cystectomy with bilateral pelvic lymph node dissection constitute the standard treatment for non-muscle invasive or very high-risk non-muscle invasive bladder cancer, respectively. However, survival expectations have not shown to improve in the last 20 years, and new diagnostic and therapeutic tools are urgently needed to improve the outcomes of this potentially lethal disease. |
| format | Online |
| id | doab-20.500.12854ir-69079 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2021 |
| publishDateRange | 2021 |
| publishDateSort | 2021 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-690792024-03-30T23:21:50Z Outcomes and Therapeutic Management of Bladder Cancer Moschini, Marco bladder cancer robotic-assisted open radical cystectomy survival propensity score age urothelial carcinoma outcome anesthesia recovery periods cognitive impairment gamma-cyclodextrins neuromuscular blockade robotic radical cystectomy glycogen clear-cell adenocarcinoma urinary bladder SEER program database female intracorporeal neobladder outcomes robotic sex-sparing methylation biomarkers FOXA1 GATA3 KRT20 molecular markers mRNA muscle-invasive bladder cancer PCR human epidermal growth factor receptor 2 indoleamine 2,3-dioxygenase programmed death ligand-1 immunotherapy nodal disease pN1 neoadjuvant adjuvant chemotherapy n/a thema EDItEUR::M Medicine and Nursing Bladder cancer is the second most common genitourinary malignancy, with 81,190 estimated new diagnoses in 2018, in the United States alone. Transurethral resection of the bladder and radical cystectomy with bilateral pelvic lymph node dissection constitute the standard treatment for non-muscle invasive or very high-risk non-muscle invasive bladder cancer, respectively. However, survival expectations have not shown to improve in the last 20 years, and new diagnostic and therapeutic tools are urgently needed to improve the outcomes of this potentially lethal disease. 2021-05-01T15:40:39Z 2021-05-01T15:40:39Z 2020 book ONIX_20210501_9783039369348_825 9783039369348 9783039369355 https://directory.doabooks.org/handle/20.500.12854/69079 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books/pdfview/book/2848 https://mdpi.com/books/pdfview/book/2848 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-03936-935-5 10.3390/books978-3-03936-935-5 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783039369348 9783039369355 120 Basel, Switzerland open access |
| spellingShingle | bladder cancer robotic-assisted open radical cystectomy survival propensity score age urothelial carcinoma outcome anesthesia recovery periods cognitive impairment gamma-cyclodextrins neuromuscular blockade robotic radical cystectomy glycogen clear-cell adenocarcinoma urinary bladder SEER program database female intracorporeal neobladder outcomes robotic sex-sparing methylation biomarkers FOXA1 GATA3 KRT20 molecular markers mRNA muscle-invasive bladder cancer PCR human epidermal growth factor receptor 2 indoleamine 2,3-dioxygenase programmed death ligand-1 immunotherapy nodal disease pN1 neoadjuvant adjuvant chemotherapy n/a thema EDItEUR::M Medicine and Nursing Outcomes and Therapeutic Management of Bladder Cancer |
| title | Outcomes and Therapeutic Management of Bladder Cancer |
| title_full | Outcomes and Therapeutic Management of Bladder Cancer |
| title_fullStr | Outcomes and Therapeutic Management of Bladder Cancer |
| title_full_unstemmed | Outcomes and Therapeutic Management of Bladder Cancer |
| title_short | Outcomes and Therapeutic Management of Bladder Cancer |
| title_sort | outcomes and therapeutic management of bladder cancer |
| topic | bladder cancer robotic-assisted open radical cystectomy survival propensity score age urothelial carcinoma outcome anesthesia recovery periods cognitive impairment gamma-cyclodextrins neuromuscular blockade robotic radical cystectomy glycogen clear-cell adenocarcinoma urinary bladder SEER program database female intracorporeal neobladder outcomes robotic sex-sparing methylation biomarkers FOXA1 GATA3 KRT20 molecular markers mRNA muscle-invasive bladder cancer PCR human epidermal growth factor receptor 2 indoleamine 2,3-dioxygenase programmed death ligand-1 immunotherapy nodal disease pN1 neoadjuvant adjuvant chemotherapy n/a thema EDItEUR::M Medicine and Nursing |
| topic_facet | bladder cancer robotic-assisted open radical cystectomy survival propensity score age urothelial carcinoma outcome anesthesia recovery periods cognitive impairment gamma-cyclodextrins neuromuscular blockade robotic radical cystectomy glycogen clear-cell adenocarcinoma urinary bladder SEER program database female intracorporeal neobladder outcomes robotic sex-sparing methylation biomarkers FOXA1 GATA3 KRT20 molecular markers mRNA muscle-invasive bladder cancer PCR human epidermal growth factor receptor 2 indoleamine 2,3-dioxygenase programmed death ligand-1 immunotherapy nodal disease pN1 neoadjuvant adjuvant chemotherapy n/a thema EDItEUR::M Medicine and Nursing |
| url | ONIX_20210501_9783039369348_825 |